Quantcast
Last updated on April 21, 2014 at 5:21 EDT

Latest kidney cancer Stories

2012-10-31 07:27:36

CLEVELAND, Oct. 31, 2012 /PRNewswire/ -- A first-of-its-kind clinical trial conducted at University Hospitals (UH) Case Medical Center Seidman Cancer Center has shown encouraging results for the use of stereotactic radiosurgery to treat kidney cancer. This non-invasive treatment technique may represent a potential new non-surgical option for patients with this deadly disease who have limited treatment options. Rod Ellis, MD, lead author of the study along with Lee Ponsky, MD, who is the...

2012-10-23 07:28:13

SAN DIEGO, Oct. 23, 2012 /PRNewswire/ -- OncoSec Medical Inc. (OTCBB: ONCS), a company developing its advanced-stage ImmunoPulse DNA-based immunotherapy and NeoPulse therapies to treat solid tumor cancers, announced positive preliminary results from a Phase II multicenter trial investigating the use of ImmunoPulse in Merkel cell carcinoma (MCC) patients at the 27th Annual Meeting of the Society for Immunotherapy of Cancer (SITC 2012). The data suggest that ImmunoPulse, which locally delivers...

2012-10-17 11:58:32

Active surveillance of small kidney masses is a safe and effective alternative to immediate surgery, with similar overall and cancer specific survival rates, according to a study published in the November issue of the urology journal BJUI. The technique is primarily used to treat elderly patients who have complex health issues or decline surgery. But researchers from the Department of Urology at Churchill Hospital, Oxford, UK, say that the results of their study suggest that active...

2012-10-02 02:30:31

PHILADELPHIA, REHOVOT, Israel, and PITTSBURGH, Oct. 2, 2012 /PRNewswire/ -- Rosetta Genomics Ltd. (NASDAQ: ROSG), a leading developer and provider of microRNA-based molecular diagnostics, and Precision Therapeutics, Inc. (PTI), a life science company known for its expertise in the science of personalizing cancer therapy by advancing genomic testing and bioinformatics, today announced the commercial launch of the miRview(®) mets(2 )assay in the U.S. oncology market. miRview(®)...

2012-09-27 22:15:44

Researchers at the University of California, San Diego School of Medicine have found that recovery from an emerging, minimally invasive surgical technique called Laparo-Endoscopic Single-Site Surgery (LESS) was less painful for kidney cancer patients than traditional laparoscopic surgery. Study results were published in the September online edition of Urology. "In the largest prospective study of kidney cancer patients to date, the UC San Diego study showed less use of narcotic pain...

2012-08-01 10:42:19

A potentially powerful new approach to treating two lethal metastatic cancers – triple negative breast cancer and clear cell renal cell carcinoma, the most common form of kidney cancer – has been discovered by researchers at Mayo Clinic in Florida. In the online issue of Molecular Cancer Therapeutics, they report that two drugs, romidepsin and decitabine, work cooperatively to activate a potent tumor suppressor gene that is silenced in these cancers. Once the gene, secreted...

2012-06-11 21:34:21

Study shows a cancer therapy for renal cell carcinoma patients may be affected by another anti-cancer drug Research revealed at the Society of Nuclear Medicine's 2012 Annual Meeting explores treatment with a newly developed type of radioimmunotherapy used for treating a resistant form of kidney cancer. The agent is able to hone in on the disease, called clear cell renal carcinoma, and kill the cancer by delivering radiation directly to it. However, the study shows that its effectiveness...

2012-06-06 05:34:10

(Ivanhoe Newswire) — Clinical trials have shown promising early results in patients with advanced non-small cell lung cancer, melanoma, and kidney cancer. Johns Hopkins Kimmel Cancer Center is leading a clinical study testing experimental drugs aimed at restoring the immune system´s ability to spot and attack cancer. “Based on the positive response rates to these drugs and longevity of many of these responses, we believe that new clinical trials should move...

2012-06-04 19:20:21

Agent benefits melanoma and lung cancer as well An antibody that helps a person's own immune system battle cancer cells shows increasing promise in reducing tumors in patients with advanced kidney cancer, according to researchers at Beth Israel Deaconess Medical Center. The results of an expanded Phase 1 trial presented at the American Society of Clinical Oncology's annual conference in Chicago, showed that some patients treated with a fully human monoclonal antibody developed by...

2012-05-21 20:18:20

Folic acid fortification of foods may reduce the incidence of the most common type of kidney cancer and a type of brain tumors in children, finds a new study by Kimberly J. Johnson, PhD, assistant professor at the Brown School at Washington University in St. Louis, and Amy Linabery, PhD, postdoctoral fellow at the University of Minnesota. Incidence reductions were found for Wilms' tumor, a type of kidney cancer, and primitive neuroectodermal tumors (PNET), a type of brain cancer. Since...